News | Neurological conditions

News

ADHD drugs back in stock, says manufacturer 

Exclusive: Medicines used to treat ADHD manufactured by Takeda are now available, following a period of supply issues caused by an increase in demand and production challenges.…

Published: 16 May 2024

News

Antipsychotic drugs in dementia treatment associated with range of adverse reactions

Experts say the findings suggest that the risks of prescribing antipsychotics in people with dementia “may be more severe than previously understood”.…

Published: 24 April 2024

News

More than 40% of people with ADHD waiting at least two years to access mental health service, study finds

Healthcare professionals, integrated care board commissioners and people with lived experience of ADHD all reported extended wait times for adult mental health services.…

Published: 19 April 2024

News

Erectile dysfunction drugs may reduce Alzheimer’s risk, study suggests

Results from a study of more than 260,000 men has suggested those taking erectile dysfunction drugs were 18% less likely to develop Alzheimer's disease than those not taking the drugs.…

Published: 8 February 2024

News

Medicines regulator seeks expert advice on risk of developmental disorders in children fathered by men on valproate

The Medicines and Healthcare products Regulatory Agency is to look again at evidence from a study evaluating the link between paternal valproate exposure and developmental disorders in children.…

Published: 16 January 2024

Opinion

How our integrated care system is taking steps to minimise the risks of sodium valproate

North Central London Integrated Care System has piloted new guidelines and a local dashboard to ensure there is a safety net in place for females taking sodium valproate.…

Published: 15 January 2024

Opinion

Learning and CPD: 2023 in review

Here, we look back on some of the highlights from research and learning content published in 2023 by The Pharmaceutical Journal and celebrate the valuable contributions made by our expert authors and reviewers.…

Published: 19 December 2023

News

Around 85% of patients on ADHD medication have been affected by shortages, survey indicates

A survey by ADHD UK showed that 27% of respondents received no supply of their ADHD medication, 33% had faced “long gaps” and 25% had experienced “short gaps” in the supply of their drugs.…

Published: 28 November 2023

Opinion

Pharmacists can do more to bridge the safety gaps for people with learning disabilities

People with learning disabilities are more likely to be taking multiple medicines, but labels are not designed with them in mind — it is time to pay more attention to this patient group’s needs.…

Published: 19 October 2023

Feature

Demystifying medical cannabis: five years on from legalisation

Although medical cannabis was legalised in the UK in 2018, a lack of evidence for unlicensed products has meant NHS prescribing is still extremely limited while the private market continues to grow.…

Published: 28 September 2023